Reyes; Christopher L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Reyes; Christopher L..The latest application filed is for "antibody drug conjugates that bind lgr5".
- Reyes; Christopher L. - San Diego CA
- REYES; Christopher L. - Thebarton AU
| Patent | Date |
|---|---|
| Method of treating cancer by administering an anti-LGR5 monoclonal antibody Grant 10,745,487 - Reyes , et al. A | 2020-08-18 |
| Antibody Drug Conjugates That Bind Lgr5 App 20200114017 - Reyes; Christopher L. ; et al. | 2020-04-16 |
| Methods of blocking cancer stem cell growth Grant 10,598,653 - Reyes , et al. | 2020-03-24 |
| Humanized Antibodies That Bind Lgr5 App 20190389964 - Reyes; Christopher L. ; et al. | 2019-12-26 |
| Antibody And Checkpoint Inhibitor Combination Therapy App 20190263925 - LAVRANOS; Tina Christine ; et al. | 2019-08-29 |
| Humanized antibodies that bind LGR5 Grant 10,358,500 - Reyes , et al. | 2019-07-23 |
| Administration Of An Anti-lgr5 Monoclonal Antibody App 20190100600 - Reyes; Christopher L. ; et al. | 2019-04-04 |
| Methods of inhibiting growth of a colon cancer tumor in a subject by administering monoclonal antibodies to G protein-coupled receptor 49 (GPR49) Grant 10,196,442 - Reyes , et al. Fe | 2019-02-05 |
| Humanized Antibodies That Bind Lgr5 App 20170114145 - Reyes; Christopher L. ; et al. | 2017-04-27 |
| Antibodies that bind LGR4, their use in inhibiting neoplastic cells and in treating tumors Grant 9,631,024 - Reyes , et al. April 25, 2 | 2017-04-25 |
| Humanized antibodies that bind LGR5 Grant 9,546,214 - Reyes , et al. January 17, 2 | 2017-01-17 |
| Antibodies And Methods Of Treating Cancer App 20160159903 - Reyes; Christopher L. ; et al. | 2016-06-09 |
| Antibodies That Bind Lgr4 App 20160046723 - Reyes; Christopher L. ; et al. | 2016-02-18 |
| Humanized Antibodies That Bind Lgr5 App 20160031984 - Reyes; Christopher L. ; et al. | 2016-02-04 |
| Methods of treating cancer by administering anti-GPR49 antibodies Grant 9,220,774 - Reyes , et al. December 29, 2 | 2015-12-29 |
| Anti-GPR49 monoclonal antibodies Grant 9,221,907 - Reyes , et al. December 29, 2 | 2015-12-29 |
| Methods of inhibiting solid tumor growth by administering GPR49 antibodies Grant 9,221,906 - Reyes , et al. December 29, 2 | 2015-12-29 |
| Antibodies And Methods Of Treating Cancer App 20150037324 - Reyes; Christopher L. ; et al. | 2015-02-05 |
| Anti-gpr49 Antibodies App 20140302054 - Reyes; Christopher L. ; et al. | 2014-10-09 |
| Methods Of Blocking Cancer Stem Cell Growth App 20140256041 - Reyes; Christopher L. ; et al. | 2014-09-11 |
| Stabilized Fc Polypeptides With Reduced Effector Function And Methods Of Use App 20120100140 - Reyes; Christopher L. ; et al. | 2012-04-26 |
| Anti-IGR-1R antibodies and uses thereof Grant 8,147,829 - Hariharan , et al. April 3, 2 | 2012-04-03 |
| Anti-IGF-1R antibodies and uses thereof Grant 7,612,178 - Hariharan , et al. November 3, 2 | 2009-11-03 |
| Anti-IGF-1R antibodies and uses thereof App 20070243194 - Hariharan; Kandasamy ; et al. | 2007-10-18 |
| Crystal of a transporter-ligand complex and methods of use App 20070105085 - Chang; Geoffrey ; et al. | 2007-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 